Trial Profile
Retrospective study of everolimus (EVL) along with ciclosporin-A (CSA) and tacrolimus (TAC) in heart transplant patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin; Everolimus
- Indications Heart transplant rejection
- Focus Therapeutic Use
- 05 Dec 2015 New trial record